CEO says AstraZeneca has ‘winning’ vaccine formula, 100% effective against hospitalization

The COVID-19 vaccine developed by the British drugs group AstraZeneca and the University of Oxford has achieved a “winning formula” for efficacy, the company’s chief executive says.

The vaccine, currently being evaluated by Britain’s independent medicines regulator, provides “100 percent protection” against severe COVID-19 disease requiring hospitalization, Pascal Soriot says in an interview with the Sunday Times newspaper.

He adds that he believes trials will show his firm has achieved a vaccine efficacy equal to Pfizer-BioNTech at 95 percent and Moderna at 94.5 percent.

“We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else,” the chief executive says, while saying only that data would be published at “some point.”

— AFP

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.